Impact of European benefit-risk reassessment procedures on drug prescribing practices in Denmark

被引：0
|
作者：
Hallgreen, Christine E. [1 ]
Andersen, Morten [1 ]
De Bruin, Marie L. [1 ]
机构：
[1] Univ Copenhagen, Copenhagen, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
965
引用
收藏
页码：468 / 469
页数：2
相关论文
共 50 条
  • [1] BENEFIT-RISK RELATIONSHIPS FOR RADIOGRAPHIC PROCEDURES
    KEREIAKES, JG
    MOSKOWITZ, M
    CAVANAUGH, DJ
    THOMAS, SR
    SAENGER, EL
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 1977, 22 (03): : 586 - 586
  • [2] Benefit-risk analysis for prescribing triphenylmethane dyes
    Nuernberg, W.
    Reimann, H.
    [J]. HAUTARZT, 2008, 59 (10): : 833 - 837
  • [3] Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine
    Tamura, RN
    Lu, YL
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2003, 37 (02) : 175 - 176
  • [4] Quantifying Preferences in Drug Benefit-Risk Decisions
    Tervonen, Tommi
    Angelis, Aris
    Hockley, Kimberley
    Pignatti, Francesco
    Phillips, Lawrence D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (05) : 955 - 959
  • [5] Quantitative Benefit-Risk Analysis for Evaluating Drug Therapies
    Kodell, Ralph L.
    Chen, James J.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (01) : 231 - 238
  • [6] Drug intake and pregnancy, evaluating the benefit-risk balance
    Benevent, Justine
    Lacroix, Isabelle
    [J]. ACTUALITES PHARMACEUTIQUES, 2019, 58 (588): : 21 - 27
  • [7] A Comprehensive Approach to Benefit-Risk Assessment in Drug Development
    Sarac, Sinan B.
    Rasmussen, Christian H.
    Rasmussen, Morten A.
    Hallgreen, Christine E.
    Soeborg, Tue
    Colding-Jorgensen, Morten
    Christensen, Per K.
    Thirstrup, Steffen
    Mosekilde, Erik
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (01) : 65 - 72
  • [8] FDA's Benefit-Risk Framework for Human Drugs and Biologics: Role in Benefit-Risk Assessment and Analysis of Use for Drug Approvals
    Lackey, Leila
    Thompson, Graham
    Eggers, Sara
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 170 - 179
  • [9] Benefit-risk reassessment of medicines: a retrospective analysis of all safety-related referral procedures in Europe during 2001-2012
    Bouvy, Jacoline C.
    Huinink, Lotte
    De Bruin, Marie L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (09) : 1004 - 1014
  • [10] BEST PRACTICES IN BENEFIT-RISK ANALYSIS IN FOOD, NUTRITION AND OTHER AREAS
    Verhagen, H.
    Tijhuis, M. J.
    Gunnlaugsdottir, H.
    Kalogeras, N.
    Leino, O.
    Luteijn, J. M.
    Magnusson, S. H.
    Odekerken, G.
    Pohjola, M. V.
    Tuomisto, J. T.
    Ueland, O.
    White, B. C.
    Holm, F.
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 1821 - 1821
12345